Santen Pharmaceutical Co Ltd
TSE:4536
Santen Pharmaceutical Co Ltd
Cash from Investing Activities
Santen Pharmaceutical Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Santen Pharmaceutical Co Ltd
TSE:4536
|
Cash from Investing Activities
-¥8.9B
|
CAGR 3-Years
44%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-2%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Investing Activities
-¥840.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
13%
|
CAGR 10-Years
-21%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Investing Activities
-¥201.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-45%
|
CAGR 10-Years
-7%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Investing Activities
-¥190.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-16%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Investing Activities
-¥37.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-11%
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Investing Activities
-¥846.4B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-72%
|
CAGR 10-Years
-31%
|
See Also
What is Santen Pharmaceutical Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-8.9B
JPY
Based on the financial report for Dec 31, 2023, Santen Pharmaceutical Co Ltd's Cash from Investing Activities amounts to -8.9B JPY.
What is Santen Pharmaceutical Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-2%
Over the last year, the Cash from Investing Activities growth was 75%. The average annual Cash from Investing Activities growth rates for Santen Pharmaceutical Co Ltd have been 44% over the past three years , -16% over the past five years , and -2% over the past ten years .